Free Women's Heart Screening Presented By Rush University Medical Center And The 2 BigHearts Foundation Rush University Medical Center, in conjunction with the 2 BigHearts Foundation, is offering a free women's heart screening to help women assess their cardiovascular risks. The screening includes an echocardiogram, an ECG, fasting blood sugar, lipid panel, height/weight/blood pressure, evaluation of waist circumference and BMI,
health risk assessment, and a consultation with a cardiologist or cardiology clinician.
Source: www.medicalnewstoday.comFoundation Takes Steps To Stop Breast Cancer By Sponsoring 'Walk Of Life' On April 19, USA The Joy to Life Foundation will host its seventh annual "Walk of Life" on Saturday, April 19, at Cramton Bowl in downtown Montgomery. Over 2,500 people are expected to participate this year. The "Walk of Life" is a fun-filled event that includes a 5 kilometer run/walk, the Mighty Kid's Dash, music, food and prizes.
Source: www.medicalnewstoday.comNews From The Annals Of Internal Medicine, April 15, 2008, Issue 1.
Source: www.medicalnewstoday.comBionovo Identifies And Describes ER-beta Selective Compounds For The Treatment Of Vaginal Dryness Bionovo, Inc. (Nasdaq: BNVI) will present seminal information on a new drug candidate for the treatment of vaginal dryness at the 7th Annual Oxford International Conference on the Science of Botanicals & American Society of Pharmacognosy 4th Interim Meeting, April 12-16, 2008. Scott Baggett, Ph.D.
Source: www.medicalnewstoday.comWorld's Smallest, Longest-Lasting Rechargeable Neurostimulator To Treat Chronic Pain, Receives FDA And CE Mark Approvals St. Jude Medical, Inc. (NYSE:STJ) announced U.S. Food and Drug Administration (FDA) and European CE Mark approvals of Eon Mini?, the world's smallest, longest-lasting rechargeable neurostimulator to treat chronic pain of the trunk or limbs and pain from failed back surgery. Slightly larger than the circumference of a U.S. silver dollar, the Eon Mini neurostimulator has a thin 10 mm profile and weighs 29 grams (approximately 1.0 oz.).
Source: www.medicalnewstoday.comBSI-201 Demonstrates Significant Tumor Growth Inhibition And Increased Survival Rates In Preclinical Ovarian Cancer Studies BiPar Sciences, Inc. announced positive preclinical data demonstrating the activity of its lead poly ADP-ribose polymerase (PARP) inhibitor, BSI-201, in ovarian cancer models. The results highlight the anti-tumor activity of BSI-201 through PARP activity inhibition, tumor growth suppression, and extended survival in multi-drug resistant xenograft models of ovarian cancer.
Source: www.medicalnewstoday.comOfficial Journal Of American Medical Women's Association Is Journal Of Women's Health The American Medical Women's Association (AMWA), an organization devoted to the advancement of women in
medicine and the improvement of women's
health, has named Journal of Women's
Health (http://www.liebertpub.com/jwh) as its official journal. Journal of Women's
Health is a peer-reviewed journal published by Mary Ann Liebert, Inc (
Source: www.medicalnewstoday.comNew Neuropathic Pain Guidelines For Primary Care Will Benefit Patients With Debilitating Neuropathic Pain Such As Post-Herpetic Neuralgia, UK New primary care guidelines on diagnosing and managing neuropathic pain published in Guidelines - summarising clinical guidelines for primary care will benefit sufferers of post-herpetic neuralgia (PHN), the debilitating neuropathic pain that follows a shingles infection as well as other causes of neuropathic pain.
Source: www.medicalnewstoday.com
# posted by Network @ 11:00 AM
